Gasanov V, Kashirskikh D, Khotina V, Kuzmina D, Nikitochkina S, Mukhina I
Cells. 2025; 14(5).
PMID: 40072070
PMC: 11898551.
DOI: 10.3390/cells14050341.
Kim Y, Lupatov A, Burunova V, Bagmet N, Chardarov N, Malov S
Int J Mol Sci. 2025; 25(24.
PMID: 39769138
PMC: 11676302.
DOI: 10.3390/ijms252413374.
Huang W, Li Y, Chen P, Ma K, Wang L
Stem Cell Res Ther. 2025; 16(1):3.
PMID: 39762946
PMC: 11705688.
DOI: 10.1186/s13287-024-04127-y.
Saki S, Monjezi S, Ghaffari F, Orak G, Salehipour Bavarsad S, Khedri A
Iran Biomed J. 2024; 28(5 & 6):235-44.
PMID: 39629623
PMC: 11829155.
DOI: 10.61186/ibj.4357.
Gharib O, Fahmy H, Abdou F
Dose Response. 2024; 22(3):15593258241289301.
PMID: 39483141
PMC: 11526167.
DOI: 10.1177/15593258241289301.
Innovative Strategies for Liver Transplantation: The Role of Mesenchymal Stem Cells and Their Cell-Free Derivatives.
Akabane M, Imaoka Y, Kawashima J, Endo Y, Schenk A, Sasaki K
Cells. 2024; 13(19.
PMID: 39404368
PMC: 11475694.
DOI: 10.3390/cells13191604.
Repeated Infusions of Bone-Marrow-Derived Mesenchymal Stem Cells over 8 Weeks for Steroid-Refractory Chronic Graft-versus-Host Disease: A Prospective, Phase I/II Clinical Study.
Kim N, Min G, Im K, Nam Y, Song Y, Lee J
Int J Mol Sci. 2024; 25(12).
PMID: 38928436
PMC: 11204151.
DOI: 10.3390/ijms25126731.
Stem cell-based therapy for fibrotic diseases: mechanisms and pathways.
Taherian M, Bayati P, Mojtabavi N
Stem Cell Res Ther. 2024; 15(1):170.
PMID: 38886859
PMC: 11184790.
DOI: 10.1186/s13287-024-03782-5.
Efficacy and safety of mesenchymal stem cell therapy in liver cirrhosis: a systematic review and meta-analysis.
Lu W, Qu J, Yan L, Tang X, Wang X, Ye A
Stem Cell Res Ther. 2023; 14(1):301.
PMID: 37864199
PMC: 10590028.
DOI: 10.1186/s13287-023-03518-x.
Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease.
Feng G, Valenti L, Wong V, Fouad Y, Yilmaz Y, Kim W
Nat Rev Gastroenterol Hepatol. 2023; 21(1):46-56.
PMID: 37798441
DOI: 10.1038/s41575-023-00846-4.
Isolation, culture, and delivery considerations for the use of mesenchymal stem cells in potential therapies for acute liver failure.
Yang H, Chen J, Li J
Front Immunol. 2023; 14:1243220.
PMID: 37744328
PMC: 10513107.
DOI: 10.3389/fimmu.2023.1243220.
Relationship Between Platelets and the Clinical Efficacy of Umbilical Cord Mesenchymal Stem Cells for HBV-Related Acute-on-Chronic Liver Failure and Liver Cirrhosis: A Preliminary Clinical Study.
Zhang K, Jia Y, Shu X, Yang X, Sun H, Cao H
Stem Cells Transl Med. 2023; 12(6):325-333.
PMID: 37133409
PMC: 10267574.
DOI: 10.1093/stcltm/szad023.
Mechanisms of Action of Mesenchymal Stem Cells in Metabolic-Associated Fatty Liver Disease.
Yi S, Cong Q, Zhu Y, Xu Q
Stem Cells Int. 2023; 2023:3919002.
PMID: 36644008
PMC: 9839417.
DOI: 10.1155/2023/3919002.
Current Therapeutic Options and Potential of Mesenchymal Stem Cell Therapy for Alcoholic Liver Disease.
Han J, Lee C, Hur J, Jung Y
Cells. 2023; 12(1).
PMID: 36611816
PMC: 9818513.
DOI: 10.3390/cells12010022.
ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis.
Wu B, Feng J, Guo J, Wang J, Xiu G, Xu J
Stem Cell Res Ther. 2022; 13(1):494.
PMID: 36195966
PMC: 9531400.
DOI: 10.1186/s13287-022-03049-x.
L-Theanine-Treated Adipose-Derived Mesenchymal Stem Cells Alleviate the Cytotoxicity Induced by N-Nitrosodiethylamine in Liver.
Lai Y, Sung Y, Lai Y, Chen L, Chen T, Chien C
Tissue Eng Regen Med. 2022; 19(6):1207-1221.
PMID: 36029414
PMC: 9679105.
DOI: 10.1007/s13770-022-00472-2.
Practical Considerations for Translating Mesenchymal Stromal Cell-Derived Extracellular Vesicles from Bench to Bed.
Lui P, Leung Y
Pharmaceutics. 2022; 14(8).
PMID: 36015310
PMC: 9414392.
DOI: 10.3390/pharmaceutics14081684.
Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review.
Shokravi S, Borisov V, Zaman B, Niazvand F, Hazrati R, Khah M
Stem Cell Res Ther. 2022; 13(1):192.
PMID: 35527304
PMC: 9080215.
DOI: 10.1186/s13287-022-02825-z.
Mesenchymal Stromal/Stem Cells and Their Extracellular Vesicles Application in Acute and Chronic Inflammatory Liver Diseases: Emphasizing on the Anti-Fibrotic and Immunomodulatory Mechanisms.
Hazrati A, Malekpour K, Soudi S, Hashemi S
Front Immunol. 2022; 13:865888.
PMID: 35464407
PMC: 9021384.
DOI: 10.3389/fimmu.2022.865888.
Extraembryonic Mesenchymal Stromal/Stem Cells in Liver Diseases: A Critical Revision of Promising Advanced Therapy Medicinal Products.
Shahrbaf M, Nouri M, Zarrabi M, Gramignoli R, Vosough M
Cells. 2022; 11(7).
PMID: 35406638
PMC: 8997603.
DOI: 10.3390/cells11071074.